Cardiac Cell Therapy 3.0: The Beginning of the End or the End of the Beginning?

Konstantinos E Hatzistergos; Anastasia Vedenko

doi:10.1161/CIRCRESAHA.117.311293

Cardiac Cell Therapy 3.0: The Beginning of the End or the End of the Beginning?

Circ Res. 2017 Jul 7;121(2):95-97. doi: 10.1161/CIRCRESAHA.117.311293.

Authors

Konstantinos E Hatzistergos¹, Anastasia Vedenko²

Affiliations

¹ From the Interdisciplinary Stem Cell Institute, Leonard M. Miller School of Medicine, University of Miami, FL. kchatzistergos@med.miami.edu.
² From the Interdisciplinary Stem Cell Institute, Leonard M. Miller School of Medicine, University of Miami, FL.

No abstract available

Keywords: Editorials; cardiac precursors; cardiovascular diseases; cell- and tissue-based therapy; endothelial progenitor cells; mesenchymal stromal cells.

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Biopsy
Cell- and Tissue-Based Therapy*
Heart*
Humans
Stem Cells

Grants and funding

T32 EY023194/EY/NEI NIH HHS/United States